scutellarin has been researched along with Cerebral Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, X; Liang, X; Liu, Y; Wang, C; Yang, C; Zhang, X | 1 |
| Ai, N; Cao, F; Chang, Q; Lee, SMY; Li, S; Miao, X; Yang, X; Zheng, Y | 1 |
2 other study(ies) available for scutellarin and Cerebral Hemorrhage
| Article | Year |
|---|---|
Protective effects of medicinal plant breviscapine on postcerebral hemorrhage in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Cell Adhesion Molecules; Cerebral Hemorrhage; Flavonoids; Inflammation Mediators; Neuroprotective Agents; NF-kappa B; Plants, Medicinal; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Apigenin; beta-Cyclodextrins; Biological Availability; Biotransformation; Cerebral Hemorrhage; Chemistry, Pharmaceutical; Disease Models, Animal; Excipients; Freeze Drying; Glucuronates; Nanostructures; Nanotechnology; Particle Size; Poloxamer; Prodrugs; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical; Zebrafish | 2014 |